Significant investment into Ausnutria by state-owned management fund has put the Chinese government's plans for the country's infant nutrition sector in the spotlight.
Academics, nutritionists and pharmacist have given their backing to a new an online resource dedicated to increasing awareness of extra virgin olive oil and other olive products, and to combat 'misinformation' about fats and oils.
Two Chinese private equity firms, JIC Investments and Tamar Alliance Fund, have bought a majority stake in Australian vitamin manufacturer Nature's Care for a reported A$800m.
Israeli biotechnology firm Algatechnologies (Algatech) is now the major shareholder in Kiwi astaxanthin manufacturer Supreme Health, with both companies sharing the goal of expanding further in China, as well as the wider Asia Pacific market.
Australian infant nutrition firm Wattle Health has reported record sales on the back of an expanding product range and an increasing number of export markets.
Spanish healthcare firm Bioibérica recently received authorisation to sell Mobilee, a patented natural ingredient, for use in functional foods and as a medical supplement in Australia and New Zealand.
New Zealand's supplement industry is deeply frustrated that long-awaited new regulations have been kicked into the long grass, but exports and innovation are continuing to thrive.
A New Zealand supplement and skincare firm, which manufactures horopito-based anti-candida products, has secured export deals to China, Canada and the UAE in the past year.
Swisse Wellness sales surged by 21.5% on a currency-adjusted basis to A$659.4m in 2017, thanks to clarity over cross-border e-commerce rules in China, rising demand and new product launches.
'In silico' computer modelling has been used to identify the physiological pathways of Anagenix’s gold kiwifruit powder ingredient, Livaux, revealing how it aids gut health.
The private philanthropic trust of Blackmores executive director Marcus Blackmore and the firm’s practitioner-only brand Bioceuticals have donated $1.5m to support complementary medicine research in Australia
The global health and supplement market is changing, with more people demanding transparency and authenticity. Sarah Morgan of New Zealand Story Group explains why the FernMark is a strong commercial tool for promoting and protecting New Zealand's...
The Australian supplement regulator is working to gradually withdraw a prescription potassium chloride supplement that has been found to contain lead in amounts exceeding the legal limit for human consumption.
